BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32281532)

  • 1. Fabry Disease Screening in Patients With Kidney Transplant: A Single-Center Study in Turkey.
    Erdogmus S; Kutlay S; Kumru G; Ors Sendogan D; Erturk S; Keven K; Ceylaner G; Sengul S
    Exp Clin Transplant; 2020 Aug; 18(4):444-449. PubMed ID: 32281532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening Test of Fabry Disease in Patients with Renal Replacement Therapy in the City of Modena].
    Alfano G; Ganda N; Cerami C; Mori G; Fontana F; Cappelli G
    G Ital Nefrol; 2018 Mar; 35(2):. PubMed ID: 29582965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Fabry disease in patients undergoing dialysis for chronic renal failure in Turkey: identification of new case with novel mutation.
    Okur I; Ezgu F; Biberoglu G; Tumer L; Erten Y; Isitman M; Eminoglu FT; Hasanoglu A
    Gene; 2013 Sep; 527(1):42-7. PubMed ID: 23756194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey.
    Huzmeli C; Candan F; Alaygut D; Bagci G; Akkaya L; Bagci B; Sozmen EY; Kurtulgan HK; Kayatas M
    Biochem Genet; 2016 Aug; 54(4):448-456. PubMed ID: 27105876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey.
    Yalın SF; Eren N; Sinangil A; Yilmaz VT; Tatar E; Ucar AR; Sevinc M; Can Ö; Gurkan A; Arik N; Alisir Ecder S; Uyar M; Yasar M; Gulcicek S; Mese M; Dheir H; Cakir U; Köksal Cevher Ş; Turkmen K; Guven B; Guven Taymez D; Erkalma Senates B; Ecder T; Kocak H; Uslu A; Demir E; Basturk T; Ogutmen MB; Kinalp C; Dursun B; Bicik Bahcebasi Z; Sipahi S; Dede F; Oruc M; Caliskan Y; Genc A; Yelken B; Altıparmak MR; Turkmen A; Seyahi N
    Nephron; 2019; 142(1):26-33. PubMed ID: 30739116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study.
    Yılmaz M; Uçar SK; Aşçı G; Canda E; Tan FA; Hoşcoşkun C; Çoker M; Töz H
    Transplant Proc; 2017 Apr; 49(3):420-424. PubMed ID: 28340804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients.
    De Schoenmakere G; Poppe B; Wuyts B; Claes K; Cassiman D; Maes B; Verbeelen D; Vanholder R; Kuypers DR; Lameire N; De Paepe A; Terryn W
    Nephrol Dial Transplant; 2008 Dec; 23(12):4044-8. PubMed ID: 18596132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study.
    Yeniçerioğlu Y; Akdam H; Dursun B; Alp A; Sağlam Eyiler F; Akın D; Gün Y; Hüddam B; Batmazoğlu M; Gibyeli Genek D; Pirinççi S; Ersoy İR; Üzüm A; Soypaçacı Z; Tanrısev M; Çolak H; Demiral Sezer S; Bozkurt G; Akyıldız UO; Akyüz Ünsal Aİ; Ünübol M; Uslu M; Eryılmaz U; Günel C; Meteoğlu İ; Yavaşoğlu İ; Ünsal A; Akar H; Okyay P
    Ren Fail; 2017 Nov; 39(1):104-111. PubMed ID: 27832731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for Fabry disease in the north-west of Spain.
    Colon C; Ortolano S; Melcon-Crespo C; Alvarez JV; Lopez-Suarez OE; Couce ML; Fernández-Lorenzo JR
    Eur J Pediatr; 2017 Aug; 176(8):1075-1081. PubMed ID: 28646478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
    Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
    Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.
    Hasholt L; Ballegaard M; Bundgaard H; Christiansen M; Law I; Lund AM; Norremolle A; Krogh Rasmussen A; Ravn K; Tumer Z; Wibrand F; Feldt-Rasmussen U
    Scand J Clin Lab Invest; 2017 Dec; 77(8):617-621. PubMed ID: 29037082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey.
    Barman HA; Özcan S; Atıcı A; Özgökçe C; Öztürk A; Kafalı AE; Çakar NE; Tavşanlı ME; Küçük M; Şahin I; Okuyan E
    Anatol J Cardiol; 2020 Jan; 23(2):79-85. PubMed ID: 32011328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
    Veloso VSP; Ataides TL; Canziani MEF; Veloso MP; da Silva NA; Barreto DV; Pereira ERS; de Moura LAR; Barreto FC
    Nephron; 2018; 138(2):147-156. PubMed ID: 28892806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey: Underdiagnosis of late-onset phenotype.
    Choi JH; Lee BH; Heo SH; Kim GH; Kim YM; Kim DS; Ko JM; Sohn YB; Hong YH; Lee DH; Kook H; Lim HH; Kim KH; Kim WS; Hong GR; Kim SH; Park SH; Kim CD; Kim SM; Seo JS; Yoo HW
    Medicine (Baltimore); 2017 Jul; 96(29):e7387. PubMed ID: 28723748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Fabry disease in a predominantly hypertensive population with left ventricular hypertrophy.
    Terryn W; Deschoenmakere G; De Keyser J; Meersseman W; Van Biesen W; Wuyts B; Hemelsoet D; Pascale H; De Backer J; De Paepe A; Poppe B; Vanholder R
    Int J Cardiol; 2013 Sep; 167(6):2555-60. PubMed ID: 22805550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients.
    Rosa Neto NS; Bento JCB; Pereira RMR
    Adv Rheumatol; 2020 Jan; 60(1):7. PubMed ID: 31907047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.
    San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR
    Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
    Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
    Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria.
    Kleinert J; Kotanko P; Spada M; Pagliardini S; Paschke E; Paul K; Voigtländer T; Wallner M; Kramar R; Stummvoll HK; Schwarz C; Horn S; Holzer H; Födinger M; Sunder-Plassmann G
    Transpl Int; 2009 Mar; 22(3):287-92. PubMed ID: 18954370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Silva CA; Barreto FC; Dos Reis MA; Moura Junior JA; Cruz CM
    Nephron; 2016; 134(4):221-230. PubMed ID: 27576502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.